Contact Information
Detailed Information
Maryland Treatment Centers Inc
-
Services:
- Young Adults
- Adults
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Outreach to persons in the community
- Comprehensive mental health assessment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Vaping not permitted
- Substance use disorder education
- Group counseling
- Hepatitis education, counseling, or support
- Individual counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Case management service
- Suicide prevention services
- Social skills development
- Transportation assistance
- Mental health services
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Detoxification
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Clonidine
- Lofexidine
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Medications for Hepatitis C treatment
- The Joint Commission
- State department of health
- Assistance with obtaining social services
- Mentoring/peer support
- Housing services
- Self-help groups
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Private for-profit organization
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Medicaid
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- HIV testing
- STD testing
- Testing for Hepatitis C (HCV)
- TB screening
- Breathalyzer or blood alcohol testing
- Female
- Male
- In-network prescribing entity
- Opioids detoxification
- Alcohol Detoxification
- Medication routinely used during detoxification
- Cocaine Detoxification
- Methamphetamines detoxification
- Benzodiazepines Detoxification
- Smoking permitted in designated area
- Anger management
- Motivational interviewing
- Brief intervention
- Relapse prevention
- Trauma-related counseling
- Cognitive behavioral therapy
- Substance use disorder counseling
- 12-step facilitation
- Outpatient methadone/buprenorphine or naltrexone treatment
- Residential/24-hour residential
- Outpatient
- Short-term residential
- Intensive outpatient treatment
- Regular outpatient treatment
- Residential detoxification
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Lofexidine or Clonidine detoxification
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Buprenorphine detoxification
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Spanish
Age Groups Accepted
Assessment/Pre-treatment
Opioid Medications used in Treatment
Facility Vaping Policy
Education and Counseling Services
Ancillary Services
Type of Care
Pharmacotherapies
License/Certification/Accreditation
Recovery Support Services
Type of Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Payment/Insurance/Funding Accepted
Testing
Gender Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Detoxification (medical withdrawal) Services
Facility Smoking Policy
Treatment Approaches
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Type of Opioid Treatment
Language Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm